MIMS Summary: NICE guidance on atopic eczema in children

The new guideline outlines best practice for the management of atopic eczema in children from birth to 12 years, covering all aspects of care from diagnosis and treatment to education and referral.

Atopic eczema, also known as atopic dermatitis, usually presents in early childhood and follows a relapsing-remitting course. In many cases the condition has a significant detrimental effect on the child’s quality of life and may also have a negative impact on the child’s parents or carers. 

KEY RECOMMENDATIONS

  • Adopt a holistic approach to assessment, noting that there is not necessarily a direct relationship between severity of eczema and impact upon quality of life.
  • Seek to identify potential trigger factors, such as irritants, skin infections or allergens including contact, food or inhalants.
  • Use a stepped approach to treatment (see below).
  • Offer children a choice of unperfumed emollients to use for everyday moisturising, washing and bathing; prescribe leave-on emollients in large quantities.
  • Tailor corticosteroid treatment to the severity of the eczema.
  • Offer children and their parents or carers advice on how to recognise and manage flares of atopic eczema, bacterial infection and eczema herpeticum.
  • Spend time educating children and their parents or carers about eczema and its treatment, providing verbal and written information as well as practical demonstrations.

Criteria for diagnosis of atopic eczema are also outlined in the guideline, as are, the circumstances under which a child should be referred for specialist dermatological advice.

 

STEPPED APPROACH TO TREATMENT – BODY*
Step treatment up or down according to severity. Treat areas of differing severity independently.

  • Clear/no evidence of active eczema – emollients.
  • Mild – emollients alone or in combination with mild-potency topical corticosteroids.
  • Moderate – emollients, moderate-potency topical corticosteroids, tacrolimus, bandages.
  • Severe – emollients, potent topical corticosteroids, tacrolimus, bandages, phototherapy, systemic therapy.

*Refer to full guidance for information on stepped treatment approach for the face and neck.


The full guideline is available at www.nice.org.uk

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...